Jove
Visualize
Contact Us

Related Concept Videos

Oogenesis02:07

Oogenesis

63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

345
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
345
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

475
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
475
Ovarian Cycle01:27

Ovarian Cycle

1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Sirt3 Protects Endometrial Receptivity In Patients With Polycystic Ovary Syndrome.
  1. Home
  3. Sirt3 Protects Endometrial Receptivity In Patients With Polycystic Ovary Syndrome.

Related Experiment Video

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.0K

SIRT3 protects endometrial receptivity in patients with polycystic ovary syndrome.

Zhonghong Zeng1,2,3,4,5, Hongying Shan1,2,3,4,6, Mingmei Lin1,2,3,4

  • 1Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing 100191, China.

Chinese Medical Journal
|May 9, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Sirtuin 3 (SIRT3) is elevated in polycystic ovary syndrome (PCOS) endometrium, improving cell health and embryo receptivity by reducing oxidative stress. This suggests SIRT3 is a potential therapeutic target for PCOS-related infertility.

Keywords:
ApoptosisEndometrial receptivityOxidative stressPolycystic ovary syndromeSirtuin 3

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

Related Experiment Videos

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.0K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Cellular metabolism

Background:

  • The sirtuin family plays vital roles in cellular processes, but its function in the human endometrium is understudied.
  • Polycystic ovary syndrome (PCOS) is associated with endometrial oxidative imbalance, potentially affecting fertility.

Purpose of the Study:

  • To investigate the expression and localization of sirtuin family members in the human endometrium.
  • To focus on sirtuin 3 (SIRT3) and its role in endometrial oxidative stress in PCOS patients.

Main Methods:

  • Collected endometrial specimens from PCOS patients and controls.
  • Utilized cell culture, bioenergetic analysis, siRNA, qPCR, Western blot, immunofluorescence, immunohistochemistry, and flow cytometry.
  • Investigated SIRT3's protective effects and mechanisms on endometrial receptivity in PCOS.

Main Results:

  • Sirtuin family members are widely expressed in the endometrium.
  • SIRT3 expression significantly increased in PCOS patients, alongside elevated endometrial antioxidants and reduced mitochondrial respiration.
  • Downregulation of SIRT3 impaired endometrial cell growth, proliferation, and embryo receptivity, indicating its role in maintaining cellular health.

Conclusions:

  • SIRT3 plays a significant role in enhancing endometrial receptivity in PCOS by mitigating oxidative stress and regulating apoptosis.
  • SIRT3 is a potential biomarker for predicting and a therapeutic target for improving endometrial receptivity in PCOS patients.